A detailed history of Bank Of America Corp transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 736,498 shares of TXG stock, worth $11.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
736,498
Previous 639,832 15.11%
Holding current value
$11.5 Million
Previous $24 Million 40.35%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$19.45 - $37.37 $1.88 Million - $3.61 Million
96,666 Added 15.11%
736,498 $14.3 Million
Q1 2024

May 15, 2024

BUY
$36.08 - $54.3 $13.4 Million - $20.1 Million
370,884 Added 137.9%
639,832 $24 Million
Q4 2023

Feb 14, 2024

BUY
$34.32 - $57.55 $1.39 Million - $2.33 Million
40,463 Added 17.71%
268,948 $15.1 Million
Q2 2023

Aug 14, 2023

SELL
$50.96 - $58.72 $8.02 Million - $9.24 Million
-157,361 Reduced 40.78%
228,485 $12.8 Million
Q1 2023

May 12, 2023

SELL
$35.33 - $55.79 $11.4 Million - $17.9 Million
-321,439 Reduced 45.45%
385,846 $21.5 Million
Q4 2022

Feb 10, 2023

SELL
$24.4 - $41.3 $827,062 - $1.4 Million
-33,896 Reduced 4.57%
707,285 $25.8 Million
Q3 2022

Nov 14, 2022

BUY
$28.48 - $52.59 $6.07 Million - $11.2 Million
213,202 Added 40.38%
741,181 $21.1 Million
Q2 2022

Aug 12, 2022

SELL
$36.95 - $82.41 $3.71 Million - $8.27 Million
-100,295 Reduced 15.96%
527,979 $23.9 Million
Q1 2022

May 16, 2022

BUY
$55.7 - $145.79 $15.3 Million - $40 Million
274,341 Added 77.51%
628,274 $47.8 Million
Q4 2021

Feb 08, 2022

SELL
$135.05 - $182.59 $3.09 Million - $4.17 Million
-22,863 Reduced 6.07%
353,933 $52.7 Million
Q3 2021

Nov 15, 2021

BUY
$145.58 - $192.14 $3.46 Million - $4.57 Million
23,762 Added 6.73%
376,796 $54.9 Million
Q2 2021

Sep 13, 2021

BUY
$134.22 - $202.37 $47.4 Million - $71.4 Million
353,034 New
353,034 $69.1 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.49B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.